Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antihypertensive Drugs: Thiazide-Class Diuretics01:15

Antihypertensive Drugs: Thiazide-Class Diuretics

2.0K
Thiazide diuretics are sulfonamide derivatives featuring a benzothiadiazine ring system in their molecular structure. Based on this structure, thiazide diuretics can be categorized into two groups: thiazide-type and thiazide-like diuretics. Thiazide-type diuretics, including hydrochlorothiazide and chlorothiazide, consist of a benzothiadiazine backbone with an attached sulfonamide group. Thiazide-like diuretics, such as chlorthalidone and indapamide, lack the thiazide ring but demonstrate...
2.0K
Antimicrobial Proteins01:23

Antimicrobial Proteins

14.7K
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
14.7K
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

10.7K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
10.7K
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

7.0K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
7.0K
Chemical Agents for Microbial Control01:27

Chemical Agents for Microbial Control

1000
Chemicals play important roles in controlling microbial growth by targeting microbial structures and functions as sanitizers, antiseptics, disinfectants, and sterilants.Alcohols are commonly used sanitizers, effectively disrupting lipid membranes, which compromises cell integrity. They are also used as antiseptics and disinfectants due to their rapid action and versatility.Phenols and their derivatives phenolics , known for denaturing proteins and disrupting cell membranes, are particularly...
1000
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

1.1K
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Design of Right-Handed D-Sulfonyl-γ-AApeptides with Broad-Spectrum Antimicrobial Activity.

Journal of medicinal chemistry·2026
Same author

Sulfonyl-γ-AAs as Turn Templates Inducing β-Sheet Conformation in Macrocyclic Peptides.

Journal of the American Chemical Society·2026
Same author

α/Sulfonyl-γ-AApeptide foldamers mitigate Alzheimer's disease pathology by stabilizing transient helical domains in Aβ.

Nature communications·2026
Same author

Inhibition of Wnt Signaling Using Axin Peptidomimetics through Direct Targeting of β-Catenin.

Journal of medicinal chemistry·2026
Same author

Structural-Functional Customization of Nanoscale Liposome-in-Liposome Systems: Precision Engineering Methodology and Artificial-Intelligence-Driven Design Prospects.

Research (Washington, D.C.)·2026
Same author

Cyclic γ-AApeptide-Based Molecular Glues for RNA m<sup>6</sup>A Editing.

ACS chemical biology·2026

Related Experiment Video

Updated: Feb 21, 2026

Author Spotlight: Scalable Drug Screening Protocol for Efficient Discovery of M. abscessus Treatments
07:50

Author Spotlight: Scalable Drug Screening Protocol for Efficient Discovery of M. abscessus Treatments

Published on: October 25, 2024

2.4K

Membrane-Active Hydantoin Derivatives as Antibiotic Agents.

Ma Su1, Donglin Xia2, Peng Teng1

  • 1Department of Chemistry, University of South Florida , 4202 E. Fowler Ave, Tampa, Florida 33620, United States.

Journal of Medicinal Chemistry
|October 7, 2017
PubMed
Summary

New hydantoin derivatives show potent antimicrobial activity against resistant bacteria. These compounds target bacterial membranes, outperforming vancomycin in a rat model of MRSA pneumonia.

More Related Videos

Regioselective O-Glycosylation of Nucleosides via the Temporary 2',3'-Diol Protection by a Boronic Ester for the Synthesis of Disaccharide Nucleosides
08:46

Regioselective O-Glycosylation of Nucleosides via the Temporary 2',3'-Diol Protection by a Boronic Ester for the Synthesis of Disaccharide Nucleosides

Published on: July 26, 2018

9.2K
Engineering Antiviral Agents via Surface Plasmon Resonance
13:00

Engineering Antiviral Agents via Surface Plasmon Resonance

Published on: June 14, 2022

2.8K

Related Experiment Videos

Last Updated: Feb 21, 2026

Author Spotlight: Scalable Drug Screening Protocol for Efficient Discovery of M. abscessus Treatments
07:50

Author Spotlight: Scalable Drug Screening Protocol for Efficient Discovery of M. abscessus Treatments

Published on: October 25, 2024

2.4K
Regioselective O-Glycosylation of Nucleosides via the Temporary 2',3'-Diol Protection by a Boronic Ester for the Synthesis of Disaccharide Nucleosides
08:46

Regioselective O-Glycosylation of Nucleosides via the Temporary 2',3'-Diol Protection by a Boronic Ester for the Synthesis of Disaccharide Nucleosides

Published on: July 26, 2018

9.2K
Engineering Antiviral Agents via Surface Plasmon Resonance
13:00

Engineering Antiviral Agents via Surface Plasmon Resonance

Published on: June 14, 2022

2.8K

Area of Science:

  • Medicinal Chemistry
  • Antimicrobial Drug Discovery

Background:

  • Hydantoin derivatives, like nitrofurantoin, are explored for low bacterial resistance rates.
  • Moderate antimicrobial activity of current hydantoins limits their long-term efficacy against antibiotic resistance.

Purpose of the Study:

  • To design novel bacterial membrane-active hydantoin derivatives.
  • To identify compounds with enhanced antimicrobial potency compared to nitrofurantoin.
  • To evaluate the potential of these derivatives in combating antibiotic-resistant pathogens.

Main Methods:

  • Design and synthesis of novel hydantoin derivatives.
  • Antimicrobial activity testing against Gram-positive and Gram-negative bacteria.
  • Assessment of resistance development inhibition, including methicillin-resistant Staphylococcus aureus (MRSA).
  • In vivo efficacy evaluation in a rat model of MRSA-induced pneumonia.

Main Results:

  • Identified hydantoin derivatives with significantly higher antimicrobial activity than nitrofurantoin.
  • Demonstrated rapid killing of bacterial pathogens and prevention of MRSA resistance development.
  • The lead compound showed superior in vivo efficacy to vancomycin in eradicating bacteria and reducing inflammation in a rat pneumonia model.

Conclusions:

  • Novel bacterial membrane-active hydantoin derivatives offer enhanced antimicrobial potency.
  • These compounds present a promising therapeutic strategy against antibiotic-resistant infections.
  • The lead compound's efficacy in vivo suggests significant clinical potential for treating MRSA infections.